Agios Pharmaceuticals (AGIO) Net Margin (2016 - 2025)
Historic Net Margin for Agios Pharmaceuticals (AGIO) over the last 12 years, with Q3 2025 value amounting to 803.05%.
- Agios Pharmaceuticals' Net Margin fell 113777400.0% to 803.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 899.83%, marking a year-over-year decrease of 29414300.0%. This contributed to the annual value of 1845.92% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Agios Pharmaceuticals' Net Margin is 803.05%, which was down 113777400.0% from 903.6% recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Net Margin ranged from a high of 10574.69% in Q3 2024 and a low of 1471.24% during Q1 2023
- Its 3-year average for Net Margin is 49.84%, with a median of 1037.61% in 2025.
- Its Net Margin has fluctuated over the past 5 years, first surged by 118089600bps in 2024, then tumbled by -113777400bps in 2025.
- Quarter analysis of 3 years shows Agios Pharmaceuticals' Net Margin stood at 1350.7% in 2023, then skyrocketed by 33bps to 899.56% in 2024, then rose by 11bps to 803.05% in 2025.
- Its Net Margin was 803.05% in Q3 2025, compared to 903.6% in Q2 2025 and 1037.61% in Q1 2025.